Interferon-gamma drives programmed death-ligand 1 expression on islet β cells to limit T cell function during autoimmune diabetes-Reference-Cited by-同舟云学术

Interferon-gamma drives programmed death-ligand 1 expression on islet β cells to limit T cell function during autoimmune diabetes

Published:2018-05-29 Issue:1 Volume:8 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Osum Kevin C.,Burrack Adam L.,Martinov Tijana,Sahli Nathanael L.,Mitchell Jason S.,Tucker Christopher G.,Pauken Kristen E.,Papas Klearchos,Appakalai Balamurugan,Spanier Justin A.,Fife Brian T.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-018-26471-9.pdf

Reference53 articles.

1. Francisco, L. M., Sage, P. T. & Sharpe, A. H. The PD-1 pathway in tolerance and autoimmunity. Immunol Rev 236, 219–242, https://doi.org/10.1111/j.1600-065X.2010.00923.x (2010).

2. Fife, B. T. & Bluestone, J. A. Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways. Immunol Rev 224, 166–182 (2008).

3. Okazaki, T. & Honjo, T. PD-1 and PD-1 ligands: from discovery to clinical application. Int Immunol 19, 813–824 (2007).

4. Wang, J. et al. Establishment of NOD-Pdcd1−/− mice as an efficient animal model of type I diabetes. Proc Natl Acad Sci USA 102, 11823–11828 (2005).

5. Nishimura, H., Nose, M., Hiai, H., Minato, N. & Honjo, T. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 11, 141–151 (1999).

Cited by 111 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decoding the immune dance: Unraveling the interplay between beta cells and type 1 diabetes;Molecular Metabolism;2024-10

2. Immune Checkpoint Inhibitors-Associated Diabetes and Ketoacidosis Were Found in FDA Adverse Event Reporting System: A Real-World Evidence Database Study;Endocrine Practice;2024-09

3. T-cell exhaustion-related genes in Graves’ disease: a comprehensive genome mapping analysis;Frontiers in Endocrinology;2024-08-22

4. CD4+ T cells reactive to a hybrid peptide from insulin-chromogranin A adopt a distinct effector fate and are pathogenic in autoimmune diabetes;Immunity;2024-08

5. Increased inhibitory surface marker PD-1 expression in CD4+T cells and Th2+T cells in allergen-specific immunotherapy;Immunobiology;2024-07